Evidence map›Paper›PMID 35201610›Full record

ArticleCancer2022

Lung cancer screening use and implications of varying eligibility criteria by race and ethnicity: 2019 Behavioral Risk Factor Surveillance System data.

Randi M Williams, Tengfei Li, George Luta, Min Qi Wang, Lucile Adams-Campbell, Rafael Meza, Martin C Tammemägi, Kathryn L Taylor

Open access · bronzeAbstract read
In one paragraph

Article in Cancer, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 2 pooled it
6.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 2 syntheses or guidelines pooled it, 43 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Lung Cancer Screening by Nativity Among Latino Community Health Center Patients.Journal of the American Board of Family Medicine : JABFM · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Estimating the Effects of Cancer Screening in Clinical Practice Settings: The Role of Selective Uptake and Suboptimal Adherence along the Cancer Screening Continuum.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2024
    Article
  17. Persistent race- and sex-based disparities in lung cancer screening eligibility.The Journal of thoracic and cardiovascular surgery · 2024
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Randi M WilliamsCancer Prevention & Control Program, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC.ORCID 0000-0003-0837-9281
Tengfei LiDepartment of Biostatistics, Bioinformatics and Biomathematics, Georgetown University, Washington, DC.ORCID 0000-0002-5026-1773
George LutaDepartment of Biostatistics, Bioinformatics and Biomathematics, Georgetown University, Washington, DC.ORCID 0000-0002-4035-7632
Min Qi WangSchool of Public Health, University of Maryland, College Park, Maryland.
Lucile Adams-CampbellCancer Prevention & Control Program, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC.ORCID 0000-0002-3444-3884
Rafael MezaDepartment of Epidemiology, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0002-1076-5037
Martin C TammemägiDepartment of Health Sciences, Brock University, St Catharines, Ontario, Canada.ORCID 0000-0002-4989-5058
Kathryn L TaylorCancer Prevention & Control Program, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC.ORCID 0000-0001-7351-0413
Georgetown University · USBrock University · CAUniversity of Maryland, College Park · USUniversity of Michigan · US

Funding

Integrating Evidence-Based Smoking Cessation Interventions into Lung Cancer Screening Programs: A Randomized TrialR01CA207228 · NCI · GEORGETOWN UNIVERSITY · PI TAYLOR, KATHRYN L · 2016 to 2020
$3.5M
A Multilevel intervention to address health disparities in lung cancer screeningK99CA256515 · NCI · GEORGETOWN UNIVERSITY · PI WILLIAMS, RANDI M. · 2021 to 2022
$236k
NCI NIH HHS K99 CA256515NCI NIH HHS R01 CA207228
6 · The paper itself

Abstract

backgroundIn 2021, the US Preventive Services Task Force (USPSTF) expanded the eligibility criteria for low-dose computed tomographic lung cancer screening (LCS) to reduce racial disparities that resulted from the 2013 USPSTF criteria. The annual LCS rate has risen slowly since the 2013 USPSTF screening recommendations. Using the 2019 Behavioral Risk Factor Surveillance System (BRFSS), this study 1) describes LCS use in 2019, 2) compares the percent eligible for LCS using the 2013 versus 2021 USPSTF criteria, and 3) determines the percent eligible using the more detailed PLCOm2012

methodsThe analysis included 41,544 individuals with a smoking history from states participating in the BRFSS LCS module who were ≥50 years old.

resultsUsing the 2013 USPSTF criteria, 20.7% (95% confidence interval [CI], 19.0-22.4) of eligible individuals underwent LCS in 2019. The 2013 USPSTF criteria was compared to the 2021 USPSTF criteria, and the overall proportion eligible increased from 21.0% (95% CI, 20.2-21.8) to 34.7% (95 CI, 33.8-35.6). Applying the 2021 criteria, the proportion eligible by race was 35.8% (95% CI, 34.8-36.7) among Whites, 28.5% (95% CI, 25.2-31.9) among Blacks, and 18.0% (95% CI, 12.4-23.7) among Hispanics. Using the 1.0% 6-year threshold that is comparable to the 2021 USPSTF criteria, the PLCOm2012

conclusionsUsing data from 20 states and using multiple imputation, higher LCS rates have been reported compared to prior BRFSS data. The 2021 expanded criteria will result in a greater number of screen-eligible individuals. However, risk-based screening that uses additional risk factors may be more inclusive overall and across subgroups. LAY SUMMARY: In 2013, lung cancer screening (lung screening) was recommended for high risk individuals. The annual rate of lung screening has risen slowly, particularly among Black individuals. In part, this racial disparity resulted in expanded 2021 criteria. Survey data was used to: 1) describe the number of people screened in 2019, 2) compare the percent eligible for lung screening using the 2013 versus 2021 guidelines, and 3) determine the percent eligible using more detailed criteria. Lung screening rates increased in 2019, and the 2021 criteria will result in more individuals eligible for screening. Using additional criteria may identify more individuals eligible for lung screening.

Indexed as

Early Detection of CancerLung NeoplasmsBehavioral Risk Factor Surveillance SystemEthnicityHumansMass ScreeningMiddle AgedUnited StatesWhite PeopleBehavioral Risk Factor Surveillance Systemlow dose computed tomographylung cancer screeningPLCOm2012 risk prediction modelrace disparitiesUS Preventive Services Task Force

Identifiers

PMID35201610
PMCPMC9007861
OpenAlexW4214501194

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.